Non-opioid pain management market set for rapid growth through 2030

The global non-opioid pain management market is projected to climb from $44.93 billion in 2025 to $68.34 billion by 2030, driven by rising chronic pain cases, concern over opioid addiction and wider use of digital and non-invasive treatments. The latest research also points to North America as the current market leader and Asia-Pacific as the fastest-growing region.

Why it matters: - Non-opioid pain management is gaining ground as providers and patients look for pain relief options that avoid the dependency risks tied to opioid medications. - The market’s growth points to broader adoption of physical therapy, digital health tools and multimodal treatment plans for acute and chronic pain.

What happened: - The Business Research Company released its "Non-Opioid Pain Management Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035." - The report puts the global market at $44.93 billion in 2025. - The market is projected to reach $48.78 billion in 2026, implying 8.6% annual growth. - The market is forecast to reach $68.34 billion by 2030, with 8.8% annual growth. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth over the forecast period.

The details: - The report says demand is being fueled by rising awareness of opioid addiction, more chronic pain cases, broader acceptance of non-opioid analgesics and growth in hospital-based pain programs. - Expansion in physical therapy and rehabilitation services is also supporting the market. - Future growth is tied to AI-powered pain assessment tools, personalized medicine and genomics, digital health technologies, remote patient monitoring and wearable healthcare devices. - The report highlights growing use of multimodal therapies that combine drug and physical treatment methods. - It also points to wider adoption of digital therapeutics for chronic pain, customized pain protocols based on patient profiles, minimally invasive and regenerative therapies, and wearable devices for continuous pain tracking and rehabilitation support. - The report defines non-opioid pain management as methods that relieve acute and chronic pain without opioid medications. - The approach aims to improve mobility, support recovery and reduce side effects and dependency risks. - Chronic pain disorders are a key growth driver because they involve persistent or recurring pain that can limit daily activity and quality of life. - Aging populations are increasing the number of patients with musculoskeletal and nerve-related pain. - Arthritis Australia reported in February 2025 that about 5.39 million Australians are living with arthritis, a 31% increase since 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company says its 2026 reports now include market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables. - Download a free sample of the report. - Read the full report.

Between the lines: - The forecast suggests non-opioid care is shifting from a niche alternative to a mainstream pain management category. - The emphasis on digital tools and wearables signals a market that is moving toward more personalized and continuously monitored care. - Regional growth patterns suggest mature markets are still dominant, but future expansion will likely come from higher-growth Asia-Pacific demand.

What's next: - Market growth will likely hinge on how quickly AI-based assessment, digital therapeutics and wearable monitoring move into routine clinical use. - Providers and device makers will be watching whether chronic pain demand keeps rising as populations age and non-invasive care expands. - The report’s forecast period runs through 2035, giving investors and healthcare companies a long runway to track adoption trends and regional shifts.

The bottom line: - Non-opioid pain management is moving into a high-growth phase, with strong demand, broadening treatment options and a clear shift toward safer alternatives to opioids.